Dragon Boat Biopharmaceutical

Company Drug

Sanjin Pharma’s Subsidiary Gets NMPA Nod for BC007 Cancer Study

Fineline Cube Aug 17, 2022

China-based Guilin Sanjin Pharmaceutical Co. Ltd (SHE: 002275) announced that its subsidiary, Dragon Boat Biopharmaceutical...

Company Drug

Sanjin Pharma’s Subsidiary Gets FDA Nod for BC007 Cancer Drug Trial

Fineline Cube Aug 1, 2022

China-based Guilin Sanjin Pharmaceutical Co. Ltd (SHE: 002275) announced that its subsidiary, Dragon Boat Pharmaceutical...

Company

Pfizer’s Q1 2025 Results: Revenues Down 6% YOY Amid Paxlovid, IRA Impact

Company

United Imaging Healthcare Reports 9.73% Revenue Decline in 2024 Financials

Company Deals

Innovent Biologics Expands Clinical Partnership with ImmVirX to Include Hepatocellular Carcinoma

Company Drug

Boehringer Ingelheim’s Zongertinib Shows Promising Results in HER2-Mutant NSCLC Trial